{
    "2019-03-22": [
        [
            {
                "time": "2018-03-22",
                "original_text": "药明康德(02359.HK)3月22日耗资142.72万元回购3.13万股限制性A股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "回购",
                        "限制性A股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-annual",
                "original_text": "药明康德2018年净利润增长八成，董事长成上交所首届科技创新咨询委候选人",
                "features": {
                    "keywords": [
                        "药明康德",
                        "净利润",
                        "增长",
                        "科技创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-annual",
                "original_text": "药明康德预计2019年对全资子公司及控股子公司累计提供不超20亿元担保，大额借贷担保",
                "features": {
                    "keywords": [
                        "药明康德",
                        "担保",
                        "子公司",
                        "借贷"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-annual",
                "original_text": "药明康德发布2018年度报告，业绩保持强劲增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "年度报告",
                        "业绩",
                        "增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-annual",
                "original_text": "药明康德上市首份年报：2018年净利润同比增长84%，拟10转4派5.8元",
                "features": {
                    "keywords": [
                        "药明康德",
                        "年报",
                        "净利润",
                        "分红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}